IPW
HALO icon

Impact Partnership Wealth’s Halozyme HALO Stock Holding History

Impact Partnership Wealth’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$466K Buy
7,214
+552
+8% +$38.9K 0.06% 210
2025
Q4 		$448K Buy
+6,662
New +$448K 0.06% 212

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Impact Partnership Wealth's HALO Position: Q1 2026 in Review

Impact Partnership Wealth increased its Halozyme (HALO) stake by 8.3% in Q1 2026, buying an estimated $38.9K and bringing the position to 7,214 shares worth $466K. The position accounts for 0.06% of the portfolio, ranked #210.

Impact Partnership Wealth first reported a position in HALO in Q4 2025 and has held it in 2 quarters since. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Impact Partnership Wealth held 7,214 shares of Halozyme worth $466K as of Q1 2026.
  • Impact Partnership Wealth bought 552 Halozyme shares in Q1 2026, an estimated $38.9K.
  • Halozyme made up 0.06% of Impact Partnership Wealth's portfolio in Q1 2026, its #210 holding.
  • Impact Partnership Wealth first reported a position in Halozyme in Q4 2025 and has held it in 2 quarters since.
  • 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Impact Partnership Wealth's 13F filing for Q1 2026, filed 23 Apr 2026.